See if you qualify for Equifax's $100 million settlement and learn how to spot mistakes on your credit report

Equifax agreed to a $100 million settlement over incorrect credit scores reported in 2022. Eligible consumers may receive $95-$280. Claims must be filed by Dec. 28, 2026. Equifax denies wrongdoing, citing most scores unchanged. The settlement, if approved, would be the largest under the Fair Credit Reporting Act.

Original reporting
Published Oct 23, 2026, 12:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 23, 2026, 1:41 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
See if you qualify for Equifax's $100 million settlement and learn how to spot mistakes on your credit report — source image
Decision brief

The 30-second read

Low
01

Why it matters

The settlement resolves claims but does not alter Equifax's operations; no immediate market‑moving effect for publicly traded peers.

02

Market read

Low trading relevance; the news is primarily consumer‑protection information with no listed‑company ticker.

03

What to watch

Potential future litigation risk if similar coding errors recur, affecting industry reputation.

Relevance 4/10Novelty 5/10Timing: deadline Dec 28 2026

Background

Equifax, a major U.S. credit bureau, reached a $100 million class‑action settlement over a 2022 coding error that produced inaccurate credit scores.

Market effects

Limited impact on credit‑reporting sector; may prompt tighter compliance reviews.

U.S. consumer‑credit market sees modest attention; no broad regional effect.

Minimal global relevance; settlement pertains to U.S. consumers and a private firm.

Counterpoint

Some investors may view the settlement as a catalyst for tighter data‑quality standards, potentially benefiting competitors.

Key entities

  • Equifax

    Private credit reporting agency subject of the settlement.

Related articles

$EFXMed

Why Equifax (EFX) stock is down today

Equifax (EFX) shares fell 2.7% after RBC downgraded the stock to Sector Perform and raised its price target to $189. The downgrade cited valuation concerns and operating issues, including mortgage market weakness and regulatory risks. The stock later recovered slightly to $178.03, down 2.4%. Equifax's shares are down 16.8% year-to-date and 22.3% below their 52-week high.

$LMTHighAI 8/10

Lockheed Martin, Blackstone and P&G Beat Q3 Estimates as $14 Billion Deal Wave and $317.5 Million IPO Reshape US Markets

Lockheed Martin (LMT) reported Q3 EPS of $7.97, beating estimates, and raised its full-year revenue forecast to $80B-$82B. Blackstone (BX) beat EPS estimates with $1.32, and shares rose 8.4%. Procter & Gamble (PG) reported Q1 EPS of $2.00, beating estimates, with sales up 4%. Equifax (EFX) saw Q3 revenue rise 10%, with mortgage revenue up 15%, despite market weakness. Shares of all companies rose following earnings reports.

$EFXMed

Why Equifax (EFX) stock is trading up today

Equifax (EFX) stock rose 6.3% after Argus upgraded it to Buy with a $200 target, citing growth and a dividend increase. Q3 earnings beat estimates at $2.26 per share, with revenue up 9.6% to $1.69B. The stock is down 12.6% YTD and 20% below its 52-week high.